LITIMEDA-SR 400

Litimeda-SR 400 is a pharmaceutical formulation containing Lithium Carbonate 400 mg in an extended-release tablet dosage form. It is part of the mood stabiliser segment of the pharmaceutical product portfolio and is formulated for professional pharmaceutical supply and institutional procurement.

Each tablet contains Lithium Carbonate 400 mg in a sustained-release formulation. The extended-release dosage form is an important product specification for healthcare professionals, hospital pharmacies and pharmaceutical distributors when identifying and differentiating formulations by active ingredient, strength and release characteristics.

Litimeda-SR 400 can be listed in pharmaceutical catalogues under lithium carbonate tablets, extended-release tablets and mood stabiliser formulations. Its product information supports clear identification across hospital procurement systems, pharmacy inventories and medicine databases.